The DUTCH Podcast podcast

An Update to the Serum-Saliva Debate for Transdermal Hormone Therapy Monitoring

0:00
1:07:59
Manda indietro di 15 secondi
Manda avanti di 15 secondi

Send us Fan Mail

In this episode, Dr. Mark Holthouse joins Dr. Jaclyn Smeaton and DUTCH founder Mark Newman to take a closer look at a recent peer-reviewed publication from Precision Analytical, Inc. in Frontiers in Reproductive Health, examining how different testing methods hold up when it comes to monitoring male TRT in clinical practice.

Their discussion also covers:

  • Common misconceptions about how creams and gels show up in saliva testing and why the numbers can be misleading
  • What the clinical data actually shows about dosing accuracy across different testing modalities 
  • When to use serum, urine, and other testing approaches can be leveraged to optimize treatment.
  • How under or overdosing risks can be reduced by matching the right test to the right clinical question
  • Why advancing best practices in integrative medicine requires continually revisiting what the evidence supports

Show Notes 

Read our DUTCH Article on the Frontiers study, Mark Newman’s commentary, and the full study here

Check out the resources mentioned in this episode: 

Become a DUTCH Provider to gain access to comprehensive patient reports, peer-reviewed and validated research, and expert clinical support. 

Altri episodi di "The DUTCH Podcast"